Technology
Health
Medical
electroCore
$3.009876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.79 (-20.84%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell electroCore and other stocks, options, ETFs, and crypto commission-free!
About
electroCore, Inc. Common Stock, also called electroCore, is a commercial-stage bio-electronic medicine company, with a platform non-invasive vagus nerve stimulation therapy focuses on neurology and rheumatology. Read More The company's therapy, gammaCore, has pharmacologic effects on the peripheral and central nervous systems, which modulate neurotransmitters and immune function. It focuses on acute treatment of migraine and episodic cluster headache. The company was founded by Joseph P. Errico, Steve Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Morris Plains, NJ.
Employees
91
Headquarters
Basking Ridge, New Jersey
Founded
2005
Market Cap
88.35M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
119.48K
High Today
$3.79
Low Today
$2.82
Open Price
$3.75
Volume
301.82K
52 Week High
$20.25
52 Week Low
$2.82
Collections
Technology
Health
Medical
Therapy
2018 IPO
US
North America
News
Yahoo FinanceMay 8
electroCore to Announce First Quarter 2019 Financial Results on Tuesday, May 14
Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J., May 08, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a commercial-stage bioelectronic medicine company, announced that it will report first quarter ended March 31, 2019 financial results after the close of the market on Tuesday May 14, 2019. Management will host a conference call and webcast at 4:30pm Eastern Time to discuss the financial results and answer questions. Tuesday, May 14 @ 4:30pm Eastern Time Domestic: 877-407-4018...
Price Paid on Robinhood
50% Lower
Right Now
52 Week Low
$2.82
Average Price Paid
$6.03
52 Week High
$20.25
Earnings
-$0.54
-$0.51
-$0.48
-$0.45
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.54 per share
Actual
-$0.47 per share